We invest in great companies at a time when they are still very small


13 December 2007
Ascendis Pharma A/S completes € 17.6 Million Series-A Financing

6 September 2007
IDEA AG concludes License Agreement for its innovative targeted analgesic, Diractin®, with Alpharma

29 May 2007
ItN Nanovation AG: construction license facilitates commencement systems marketing in billion-strong market for waste water treatment

16 May 2007
IDEA AG submits marketing application for its innovative targeted analgesic, Diractin®, to EMEA

20 April 2007
Publication on the Rapid Prediction of Nano-Emulsion Stability using Ultrasonic Resonator Technology

12 April 2007
CINVENTION and Relisys Medical Devices Enrol First Patients in Clinical Trial of the Corel + C Drug-Eluting Stent

Homepage Erstellung und Pflege: Superweb Homepage-Erstellung Version 1.0